 |
市场调查报告书
商品编码
1449650
脂肪酰胺市场：依产品类型、依型态、按地区Fatty Amides Market, By Product Type (Erucamide, Oleamide, Stearamide, Behenamide), By Form (Powder, Beads, Micro-beads, Pastilles), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) |
||||||
2024年脂肪酰胺市场规模为4.282亿美元，预计2024年至2031年复合年增长率为4.1%，2031年达到5.681亿美元。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2023/2024年市场规模 | 4.282 亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测期间 2023/2024 至 2030/2031 年复合年增长率： | 4.10% | 2030/2031价值预测 | 5.681 亿美元 |
近年来，由于塑胶、橡胶和油漆等各种最终用途行业的应用不断扩大，全球脂肪酰胺市场出现了显着增长。脂肪酰胺在这些行业中主要用作润滑剂、助流剂和防喷霜剂。脂肪酰胺具有优良的性能，如良好的热稳定性、耐化学性和宽的液体范围。此外，可再生动植物来源的脂肪酰胺有助于减少对石油产品的依赖，促进市场成长。然而，原物料价格波动仍然是一个关键挑战。然而，人们对生物基化学品的永续性和优势的认识不断提高，正在扩大脂肪酰胺製造商的商机。脂肪酰胺，通常称为脂肪酸酰胺，是有机脂肪酸的衍生物，其中OH基团被NH2（胺）基取代。依产品类型，脂肪酰胺分为Erucamide、油酰胺、硬脂酰胺和Behenamide。含有脂肪酰胺的产品以珠子、粉末状，有时还有锭剂的形式出售。
市场动态：
全球脂肪酰胺市场的成长是由塑胶和橡胶行业的成长以及生物基化学品的广泛普及导致的需求增加等因素所推动的。脂肪酰胺在塑胶和橡胶配方中主要用作润滑剂、脱模剂和防粘连剂。此外，对高性能产品的需求不断增长正在推动脂肪酰胺的消费。然而，价格波动和棕榈油、椰子油、Tall oil原料供应不稳定是主要挑战。此外，有关石化产品排放的严格环境法规正在限制市场成长。另一方面，永续性和对生物基化学品不断变化的偏好带来了巨大的机会。领先公司正在投资研发，以开发新的应用领域和环保生产技术。
本研究的主要特点
- 该报告对脂肪酰胺市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
- 它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
- 它根据公司亮点、产品系列、主要亮点、财务业绩和策略等参数，对脂肪酰胺市场的主要企业进行了介绍。
- 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
- 脂肪酰胺市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 个人护理行业需求增加
- 替代品的可用性
- 利基泡沫的脂肪酸酰胺创新
- 主要亮点
- 监管场景
- 最近的趋势
- 产品发布/核准
- PEST分析
- 波特的分析
- 合併、收购和合作
第四章脂肪酰胺市场－冠状病毒（COVID-19）大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第五章脂肪酰胺市场，依产品类型，2019-2031
- Erucamide
- 硬脂酰胺
- Behenamide
- 油酸酰胺
第六章脂肪酰胺市场，依型态划分，2019-2031
- 粉末、珠子
- 微珠
- 菱形
第七章脂肪酰胺市场，按地区，2019-2031
- 2024 年及 2031 年按地区分類的市场占有率分析 (%)
- 2020-2031与前一年同期比较成长分析（按地区）
- 各国的趋势
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中东/非洲
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 南非
- 中部非洲
- 北非
第八章 竞争格局
- 公司简介
- Lonza
- Novartis International AG
- BASF AG
- SEQENS
- Carbogen Amcis AG
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb
- Pfizer Inc.
- Roche Diagnostics
- Boehringer Ingelheim
- Merck &Co
- Bayer AG
- Ajinomoto Bio-Pharma Services
- Cambrex Corporation
- Minakem
- Sanofi Aventis
第9章 章节
- 参考
- 调查方法
- 关于出版商
The fatty amides Market size is valued at US$ 428.2 Mn in 2024 and is expected to reach US$ 568.1 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 428.2 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 - 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 4.10% | 2030/2031 Value Projection: | US$ 568.1 Mn |
The global fatty amides market has been witnessing significant growth in recent years driven by growing applications in various end-use industries such as plastics, rubber, coatings, and others. Fatty amides are mainly used as lubricants, flow promoters, and anti-blooming agents in these industries. They offer excellent properties such as outstanding thermal stability, chemical resistance, and wide liquid range. Additionally, fatty amides derived from renewable plant and animal sources help reduce dependency on petroleum-based products, thereby boosting the market growth. However, fluctuations in raw material prices remain a key challenge. But growing awareness about sustainability and benefits of bio-based chemicals is expanding opportunities for fatty amides manufacturers. Fatty amides, often termed fatty acid amides, are derivatives of organic fatty acids where an OH group is replaced by an NH2 (amine) group. Depending on the type of product, fatty amides are differentiated as erucamides, oleamides, stearamides, and behenamides. Products containing fatty amides are available in beads, powders, and sometimes also the pastilles form.
Market Dynamics:
The growth of the global fatty amides market is driven by factors such as increasing the demand from the thriving plastics and rubber industries and widespread adoption of bio-based chemicals. Fatty amides find major applications as lubricants, release agents, and anti-blocking agents in plastics and rubber formulations. Additionally, the growing need for high-performance products is propelling the consumption of fatty amides. However, fluctuations in prices and unreliable supply of raw materials such as palm oil, coconut oil, and tall oil pose a major challenge. Furthermore, strict environmental regulations regarding emissions from petrochemical-based products restrain the market growth. Meanwhile, shifting preference toward sustainability and bio-based chemicals presents significant opportunities. Leading players are investing in R&D to develop novel application areas and green production technologies.
Key Features of the Study:
- This report provides an in-depth analysis of the fatty amides market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the fatty amides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Haihang Industries Co. Ltd., Croda International Plc., PMC Biogenix Inc., Fine Organic Industries Pvt. Ltd., Nippon Fine Chemicals Co., Ltd., Kao Corporation, Italmatch Chemicals S.p.A., Sichuan Tianyu Oleochemical Co., Ltd., and Nippon Kasei Chemical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The fatty amides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation:
- Fatty Amides Market, By Product Type
- Erucamides
- Oleamides
- Stearamides
- Behenamides
- Fatty Amides Market, By Form
- Powder, Beads
- Micro-beads
- Pastilles
- Fatty Amides Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Top Companies in the Fatty Amides Market:
- Haihang Industries Co. Ltd.
- Croda International Plc.
- PMC Biogenix Inc.
- Fine Organic Industries Pvt. Ltd.
- Nippon Fine Chemicals Co., Ltd.
- Kao Corporation
- Italmatch Chemicals S.p.A.
- Sichuan Tianyu Oleochemical Co., Ltd.
- Nippon Kasei Chemical Co., Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Fatty Amides Market, By Product Type
- Fatty Amides Market, By Form
- Fatty Amides Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing demand from the personal care industry
- Restraints
- Availability of substitutes
- Opportunities
- Innovation of fatty amides for niche Forms
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Fatty Amides Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Fatty Amides Market, By Product Type, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Erucamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Stearamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Behenamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Oleamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
6. Fatty Amides Market, By Form , 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Powder, Beads
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Micro-beads
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
- Pastilles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
7. Fatty Amides Market , By Region, 2019-2031, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 - 2031
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profile
- Lonza
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BASF AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SEQENS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Carbogen Amcis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ajinomoto Bio-Pharma Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cambrex Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Minakem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi Aventis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About us
